Mònica Sánchez-Guixé

8PUBLICATIONS
79CO-AUTHORS
Molecular targetsPredictive and prognostic markersProgramming languagesCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 13, 2026
Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

|Jul 10, 2026
Variable latency between the founder genetic event and rhabdoid tumor expansion.

|Dec 11, 2024
OpenVariant: a toolkit to parse and operate multiple input file formats.

David Martínez-Millán, Federica Brando, Miguel L Grau

|Mar 19, 2024
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues.

Mònica Sánchez-Guixé, Ferran Muiños, Morena Pinheiro-Santin

|Sep 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.

Mandy Lawson, Natalie Cureton, Susana Ros

|Nov 14, 2022
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.

Marta Palafox, Laia Monserrat, Meritxell Bellet

Pageof 2

Frequent Collaborators

5 joint publications

Violeta Serra

4 joint publications

Nuria Lopez-Bigas

4 joint publications

Mafalda Oliveira

4 joint publications

Abel Gonzalez-Perez